Antibiotics | Escherichia coli n : 64 | Salmonella enterica n: 41 | ||||
---|---|---|---|---|---|---|
Resistant | Intermediate | Susceptible | Resistant | Intermediate | Susceptible | |
n (%) | n (%) | |||||
Gentamicin | 7 (10.9) | 0 (0.0) | 57 (89.1) | 2 (4.9) | 0 (0.0) | 39 (95.1) |
Tobramycin | 3 (4.7) | 0 (0.0) | 61 (95.3) | 0 (0.0) | 0 (0.0) | 41 (100.0) |
Imipenem | 0 (0.0) | 0 (0.0) | 64 (100.0) | 0 (0.0) | 0 (0.0) | 41 (100.0) |
Cefazolin | 64 (100.0) | 0 (0.0) | 0 (0.0) | 41 (100.0) | 0 (0.0) | 0 (0.0) |
Ceftazidime | 61 (95.3) | 0 (0.0) | 3 (4.7) | 41 (100.0) | 0 (0.0) | 0 (0.0) |
Ceftriaxone | 61 (95.3) | 0 (0.0) | 3 (4.7) | 40 (97.6) | 0 (0.0) | 1 (2.4) |
Cefepime | 59 (92.2) | 0 (0.0) | 5 (7.8) | 40 (97.6) | 0 (0.0) | 1 (2.4) |
Ciprofloxacin | 0 (0.0) | 0 (0.0) | 64 (100.0) | 0 (0.0) | 0 (0.0) | 41 (100.0) |
Ampicillin | 64 (100.0) | 0 (0.0) | 0 (0.0) | 41 (100.0) | 0 (0.0) | 0 (0.0) |
Multidrug resistance | 52 (81.3%) | 37 (90.2) |